Discontinuation report TEVA-PREGABALIN

Last updated on 2020-07-10 History
Report ID 120033
Drug Identification Number 02361183
Brand name TEVA-PREGABALIN
Common or Proper name PREGABALIN 75MG CAP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PREGABALIN
Strength(s) 75MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 60
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-03-25
Remaining supply date 2020-03-25
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-07-10 French Compare
v1 2020-07-10 English Compare